This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1995;3(3):171-3.

doi: 10.3109/10611869509015940.

Nanoparticulate systems in drug delivery and targeting

PMID: 8705247
DOI: 10.3109/10611869509015940

Editorial

Nanoparticulate systems in drug delivery and targeting

J Kreuter. J Drug Target. 1995.

. 1995;3(3):171-3.

doi: 10.3109/10611869509015940.

Author

PMID: 8705247
DOI: 10.3109/10611869509015940

No abstract available

PubMed Disclaimer

Similar articles

Composite nanoparticles take aim at cancer.
Gil PR, Parak WJ. Gil PR, et al. ACS Nano. 2008 Nov 25;2(11):2200-5. doi: 10.1021/nn800716j. ACS Nano. 2008. PMID: 19206383 Review.
Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate.
Torchilin VP. Torchilin VP. Adv Drug Deliv Rev. 2005 Jan 2;57(1):95-109. doi: 10.1016/j.addr.2004.06.002. Adv Drug Deliv Rev. 2005. PMID: 15518923 Review.
Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro.
Sawant RM, Cohen MB, Torchilin VP, Rokhlin OW. Sawant RM, et al. J Drug Target. 2008 Aug;16(7):601-4. doi: 10.1080/10611860802228954. J Drug Target. 2008. PMID: 18686131
Immunoconjugates in drug delivery systems.
Cannon JB, Hui HW. Cannon JB, et al. Targeted Diagn Ther. 1990;3:121-39. Targeted Diagn Ther. 1990. PMID: 2131008 Review. No abstract available.
[Targeting therapy for malignant brain tumors].
Kochi M, Ushio Y. Kochi M, et al. Gan To Kagaku Ryoho. 1994 May;21(6):738-42. Gan To Kagaku Ryoho. 1994. PMID: 8185328 Review. Japanese. No abstract available.

See all similar articles

Cited by

Nanoparticle delivery systems in cancer vaccines.
Krishnamachari Y, Geary SM, Lemke CD, Salem AK. Krishnamachari Y, et al. Pharm Res. 2011 Feb;28(2):215-36. doi: 10.1007/s11095-010-0241-4. Epub 2010 Aug 19. Pharm Res. 2011. PMID: 20721603 Free PMC article. Review.
Creatine nanoliposome reverts the HPA-induced damage in complex II-III activity of the rats' cerebral cortex.
Mezzomo NJ, Becker Borin D, Ianiski F, Dotto Fontana B, Diehl de Franceschi I, Bolzan J, Garcez R, Grings M, Parmeggiani B, da Silva Fernandes L, de Almeida Vaucher R, Leipnitz G, Duval Wannmacher CM, Cielo Rech V. Mezzomo NJ, et al. Mol Biol Rep. 2019 Dec;46(6):5897-5908. doi: 10.1007/s11033-019-05023-y. Epub 2019 Aug 13. Mol Biol Rep. 2019. PMID: 31410688
Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.
Mc Carthy DJ, Malhotra M, O'Mahony AM, Cryan JF, O'Driscoll CM. Mc Carthy DJ, et al. Pharm Res. 2015 Apr;32(4):1161-85. doi: 10.1007/s11095-014-1545-6. Epub 2014 Dec 2. Pharm Res. 2015. PMID: 25446769 Review.
Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
Yun Y, Cho YW, Park K. Yun Y, et al. Adv Drug Deliv Rev. 2013 Jun 15;65(6):822-32. doi: 10.1016/j.addr.2012.10.007. Epub 2012 Nov 2. Adv Drug Deliv Rev. 2013. PMID: 23123292 Free PMC article. Review.
Lectin-mediated drug targeting: preparation, binding characteristics, and antiproliferative activity of wheat germ agglutinin conjugated doxorubicin on Caco-2 cells.
Wirth M, Fuchs A, Wolf M, Ertl B, Gabor F. Wirth M, et al. Pharm Res. 1998 Jul;15(7):1031-7. doi: 10.1023/a:1011926026653. Pharm Res. 1998. PMID: 9688056

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon